Ascentage Pharma Group Inc.

This study looked at adding an experimental drug, APG-1387, to standard chemotherapy for people with advanced pancreatic cancer that had stopped responding to treatment. The goal was to find the safest dose and see if the combination could shrink tumors or slow the disease. The s…

This study tested a combination of two drugs, APG-1387 and toripalimab, in 40 people with advanced solid tumors (colorectal, nasopharyngeal, or lung cancer). The goal was to find a safe dose and see if the combo could control the disease. The trial was terminated early, so result…